Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: A review of preliminary data, efficacy, and cost
Aspirin-exacerbated respiratory disease (AERD) patients with CRSwNP suffer from reduced quality of life, reduced economic productivity, and higher risk of depression and sleep dysfunction. These patients often require frequent medical and surgical therapy, including functional endoscopic sinus surge...
Saved in:
Main Authors: | Alan D. Workman, Benjamin S. Bleier |
---|---|
Format: | article |
Language: | EN |
Published: |
KeAi Communications Co., Ltd.
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/7783b942a26d4f468872f81983e19fd7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
by: Tran Locke, et al.
Published: (2020) -
Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
by: Daniel B. Spielman, et al.
Published: (2020) -
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
by: Carlo Lombardi, MD, et al.
Published: (2021) -
Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
by: Lindsey Ryan, et al.
Published: (2020) -
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
by: Kathleen Buchheit, et al.
Published: (2020)